English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Significance: Orexins-A and -B are neuropeptides that regulate arousal and sleep–wake cycles by hypothalamic signaling through the orexin-1 and -2 receptors. MK-6096 is a dual orexin receptor antagonist that is of interest for the treatment of insomnia. In the asymmetric synthesis depicted (7 steps, 37% overall), the key stereogenic steps are (1) a biocatalytic transamination (A→B) and (2) a highly diastereoselective Mukaiyama directed aldol reaction (C→D, dr > 99:1). Comment: During a previous kg-scale synthesis of MK-6096 (M. Girardin et al. Org. Process Res. Dev. 2013, 17, 61) the challenging amidation of fragments I and J required 3.4 equivalents of expensive T3P (1-propylphosphonic anhydride). In the current route the same amidation was accomplished using only 0.05 equivalents of T3P together with stoichiometric amounts of pivaloyl choride as the dehydrating agent. A mechanism for this unusual transformation is presented that implicates participation by the pyrimidine ring. C mp not reported A N

Synthesis of Dual Orexin Receptor Antagonist MK-6096